Efren Rael Kevin Rakszawski Kristian Koller Michael Bayerl Manish Butte Hong Zheng
10.1186/s40364-016-0061-8
Biomark Res
2016 Mar 9;4:7.
brentuximab cvid hodgkin lymphoma rituximab
CC BY
https://pubmed.ncbi.nlm.nih.gov/26966541/
Case Reports
PMC4785670
26966541
Treatment with rituximab and brentuximab vedotin in a patient of common variable immune deficiency-associated classic Hodgkin lymphoma
2016